CoChat

Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review

Open access
Moreno, Gerardo, Mangione, Carol M. · 2013 · Journal of the American Geriatrics Society
Cited by 65

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus ( DM ) is one of the most common chronic conditions in older adults and is often accompanied by comorbidities and geriatric syndromes. The management of cardiovascular disease risk factors in older adults with DM is important to clinicians. The literature was reviewed from 2002 to 2012 to provide an American Geriatrics Society expert panel with an evidence base for updating and making new recommendations for improving the care of older adults with type 2 DM . This review includes only the domains of the management of blood pressure, lipid control, glycemic control, and use of aspirin. Over the last 10 years, new randomized controlled trials ( RCT ) designed to study different blood pressure treatment targets did not find evidence that intensive systolic blood pressure control (<130 mmHg) resulted in lower rates of myocardial infarction and mortality than less‐intensive control. There are risks of side effects with achieving systolic blood pressure of less than 120 mmHg. Lipid‐lowering statins are effective in reducing cardiovascular events in middle‐aged and older adults, but data on niacin and fibrates is limited. Trials of statins and other lipid‐lowering agents do not evaluate the cardiovascular effects on outcomes from treating lipids to different low‐density lipoprotein cholesterol targets. No RCT s of lipid‐lowering drugs enrolled significant numbers of adults aged 80 and older with or without DM . Three major RCT s that investigated intensive glycemic control did not find reductions in primary cardiovascular endpoints, and one study reported greater mortality with glycosylated hemoglobin of less than 6%. Two recently published RCT s were designed to study the cardiovascular benefits of aspirin use by individuals with DM . Neither trial found significantly fewer primary cardiovascular endpoints with aspirin than in control groups. Overall, RCT s enrolled few adults aged 80 and older or with significant comorbidities. More research is needed for clinicians to effectively customize care to older adults with DM because of heterogeneity in health status, comorbidities, duration of disease, frailty and functional status, and differences in life expectancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgs.12513

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 27

  1. 10.1001/jama.299.14.1678 · DOI · Paper page
  2. 10.1046/j.1523-1755.2002.00213.x · DOI · Paper page
  3. 10.1136/bmj.317.7160.703 · DOI · Paper page
  4. Ninomiya T, 2010, Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the ADVANCE trial, J Hypertens, 28, 1141, 10.1097/HJH.0b013e328338a89c · DOI · Paper page
  5. 10.1097/HJH.0b013e32832d7370 · DOI · Paper page
  6. 10.1001/jama.2010.884 · DOI · Paper page
  7. 10.1161/CIRCULATIONAHA.110.016337 · DOI · Paper page
  8. 10.1056/NEJM199610033351401 · DOI · Paper page
  9. 10.1056/NEJM199811053391902 · DOI · Paper page
  10. 10.1016/S0140-6736(02)09327-3 · DOI · Paper page
  11. 10.1001/archinte.162.12.1395 · DOI
  12. 10.1001/jama.279.20.1615 · DOI · Paper page
  13. 10.2337/dc05-2415 · DOI · Paper page
  14. 10.1056/NEJMoa0806470 · DOI · Paper page
  15. 10.1056/NEJMoa0802743 · DOI · Paper page
  16. 10.1056/NEJMoa0802987 · DOI · Paper page
  17. 10.1016/S0140-6736(09)60697-8 · DOI · Paper page
  18. 10.1016/j.numecd.2009.03.021 · DOI · Paper page
  19. ET‐DRS Investigators, 1992, Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14, JAMA, 268, 1292, 10.1001/jama.1992.03490100090033 · DOI · Paper page
  20. 10.1136/bmj.296.6618.313 · DOI · Paper page
  21. 10.1056/NEJM198907203210301 · DOI · Paper page
  22. 10.1016/S0140-6736(97)11475-1 · DOI · Paper page
  23. 10.2337/diacare.26.12.3264 · DOI · Paper page
  24. 10.2337/dc09-1297 · DOI · Paper page
  25. 10.1097/MAJ.0b013e3181f1fba8 · DOI
  26. 10.2337/dc10-0555 · DOI · Paper page
  27. 10.1186/1745-6215-8-21 · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Moreno, G., & Mangione, C. M.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2013-11
Volume
61
Issue
11
Pages
2027-2037
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2029338738
Cited by
65
References
32
FWCI
7.55
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute on Aging (K23 AG042961-01)
  • American Federation for Aging Research
  • Hartford Foundation
  • National Institute on Minority Health and Health Disparities (R01-MD0061850-02)
  • National Institutes of Health (P30-AG021684)
  • National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute (UL1TR000124)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review. https://app.cochat.ai/papers/10.1111/jgs.12513
The paper
Moreno, G., & Mangione, C. M. (2013). Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12513

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.